1. Home
  2. BBNX vs EMBC Comparison

BBNX vs EMBC Comparison

Compare BBNX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$10.24

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.62

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBNX
EMBC
Founded
2015
1924
Country
United States
United States
Employees
423
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
521.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BBNX
EMBC
Price
$10.24
$8.62
Analyst Decision
Strong Buy
Buy
Analyst Count
9
2
Target Price
$26.22
$18.50
AVG Volume (30 Days)
1.0M
827.2K
Earning Date
04-21-2026
05-08-2026
Dividend Yield
N/A
6.79%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
N/A
N/A
Revenue This Year
$34.99
$1.17
Revenue Next Year
$34.47
N/A
P/E Ratio
N/A
$11.95
Revenue Growth
N/A
N/A
52 Week Low
$8.89
$8.47
52 Week High
$32.71
$15.55

Technical Indicators

Market Signals
Indicator
BBNX
EMBC
Relative Strength Index (RSI) 37.08 37.94
Support Level $9.91 $8.72
Resistance Level $11.92 $9.47
Average True Range (ATR) 0.66 0.36
MACD 0.14 0.05
Stochastic Oscillator 38.63 29.15

Price Performance

Historical Comparison
BBNX
EMBC

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: